or any useful rehab strategies. Proves once again there is no strategy to get all stroke survivors 100% recovered.
GENERAL OR LOCAL ANESTHESIA IN INTRA ARTERIAL THERAPY (“GOLIATH”): A RANDOMIZED TRIAL
THE
EFFECT OF ALTEPLASE ON HEALTH CARE UTILISATION AND QUALITY OF LIFE IN
SWEDEN, NORWAY AND SCOTLAND: RESULTS FROM THE 3RD INTERNATIONAL STROKE
TRIAL (IST-3)
TIME
DELAYS AND ENDOVASCULAR TREATMENT EFFECT: A PRESPECIFIED PATIENT-LEVEL
POOLED ANALYSIS OF ALL AVAILABLE TRIALS. The VISTA-Endovascular
Collaborators
Endovascular
revascularization with contact aspiration versus stent retriever in
acute Ischemic stroke with large vessel occlusion. The ASTER TRIAL. A
Randomized Clinical Trial
MODIFIERS
OF ENDOVASCULAR TREATMENT EFFECT: A PRESPECIFIED PATIENT-LEVEL POOLED
ANALYSIS OF ALL AVAILABLE TRIALS. The VISTA-Endovascular Collaborators
THROMBOLYSIS OR ANTICOAGULATION FOR CEREBRAL VENOUS THROMBOSIS (TO-ACT): A RANDOMISED CONTROLLED TRIAL
Real-World
Applicability of Endovascular Therapy in ICA and/or MCA-M1 Occlusions
Treated in the 6–24-hour Window: Subgroup Analysis of the Prospective
Trevo Registry
A
RANDOMISED, PLACEBO-CONTROLLED PHASE 2 TRIAL OF SUBCUTANEOUS
INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE ISCHAEMIC STROKE
(SCIL-STROKE)
A
RANDOMISED, PLACEBO-CONTROLLED PHASE 2 TRIAL OF SUBCUTANEOUS
INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE ISCHAEMIC STROKE
(SCIL-STROKE)
Feasibility and Safety of Mild Therapeutic Hypothermia in Poor-Grade Subarachnoid Hemorrhage: a Prospective Pilot Study
EFFECT
OF INTENSIVE VERSUS GUIDELINE ANTIPLATELET THERAPY IN MAJOR ISCHAEMIC
STROKE: DATA FROM THE TRIPLE ANTIPLATELETS FOR REDUCING DEPENDENCY IN
ISCHAEMIC STROKE (TARDIS) TRIAL
Effect
of intravenous glyburide on adjudicated edema endpoints in the
Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial
Head positioning in high risk patients: post-hoc subgroup analysis of HeadPoST, an international cluster crossover trial
SAFETY
AND EFFICACY OF INTRA-ARTERIAL INFUSION OF BONE MARROW DERIVED
MONONUCLEAR CELLS IN SUBACUTE ISCHEMIC STROKE: RANDOMIZED OPEN LABELED
CLINICAL TRIAL
INTRATHECAL
BACLOFEN THERAPY COMPARED TO THE CONVENTIONAL TREATMENT: EFFICACY
RESULTS IN THE MANAGEMENT OF POST-STROKE SPASTICITY OF THE SISTERS
RANDOMIZED CONTROL TRIAL
CTX
HUMAN STEM CELLS IN STROKE RECOVERY: 6 MONTH OUTCOMES OF THE PILOT
INVESTIGATION OF STEM CELLS IN STROKE PHASE 2 EFFICACY (PISCES II) STUDY
TALOS:
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO
TEST THE VASCULAR AND NEUROPROTECTIVE EFFECTS OF CITALOPRAM IN PATIENTS
WITH ACUTE ISCHEMIC STROKE
PRASUGREL
VERSUS CLOPIDOGREL IN ISCHEMIC STROKE PATIENTS: A MULTICENTER,
RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP TRIAL (THE PRASTRO-I)
THE
FURTHER CARDIOVASCULAR OUTCOMES RESEARCH WITH PCSK9 INHIBITOR IN
SUBJECTS WITH ELEVATED RISK (FOURIER) TRIAL: EFFECT OF EVOLOCUMAB ON
CEREBROVASCULAR DISEASE
SPACE-2:
STENT-PROTECTED ANGIOPLASTY IN ASYMPTOMATIC CAROTID ARTERY STENOSIS VS.
ENDARTERECTOMY COMPARED TO BEST MEDICAL TREATMENT. ONE YEAR RESULTS
CILOSTAZOL
VERSUS ASPIRIN FOR A COGNITIVE OUTCOME IN ISCHEMIC STROKE PATIENTS WITH
HIGH RISK OF CEREBRAL HEMORRHAGE: PICASSO-COG TRIAL
RESUMPTION
OF ORAL ANTICOAGULATION AFTER INTRACEREBRAL HEMORRHAGE IS ASSOCIATED
WITH DECREASED MORTALITY AND FAVORABLE FUNCTIONAL OUTCOME
LONG-TERM
ANTITHROMBOTIC TREATMENT IN INTRACRANIAL HEMORRHAGE SURVIVORS WITH
ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
MILD STROKE DUE TO LARGE ARTERY OCCLUSION. WHEN IS IV THROMBOLYSIS NOT ENOUGH? RESULTS FROM THE SITS-ISTR REGISTRY
COMPARING
THE IMPACT OF BASELINE COLLATERAL STATUS ASSESSED BY DIFFERENT
COLLATERAL SCORES AND IMAGING MODALITIES ON OUTCOMES IN ACUTE ISCHEMIC
PATIENTS: META-ANALYSIS FROM THE HERMES-COLLABORATION
DIAGNOSIS OF COGNITIVE FUNCTIONS: PROBLEMS AND PROSPECTS
THE T3 TRIAL: TRIAGE, TREATMENT AND TRANSFER OF PATIENTS WITH STROKE IN EMERGENCY DEPARTMENTS
MR
CLEAN-NO IV: INTRAVENOUS TREATMENT FOLLOWED BY INTRAARTERIAL TREATMENT
VERSUS DIRECT INTRAARTERIAL TREATMENT FOR ACUTE ISCHEMIC STROKE CAUSED
BY A PROXIMAL INTRACRANIAL OCCLUSION
PROSPECTIVE REGISTRY OF DECOMPRESSIVE SURGERY FOR CVT PATIENTS – DECOMPRESS – 2
Solitaire™
With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT
Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation
Stroke (SWIFT DIRECT)
EARLY VERSUS LATE INITIATION OF DIRECT ORAL ANTICOAGULATION IN POST-ISCHAEMIC STROKE PATIENTS WITH ATRIAL FIBRILLATION (ELAN)
MR
CLEAN MED – THE EFFECT OF PERIPROCEDURAL MEDICATION IN PATIENTS
UNDERGOING INTRA-ARTERIAL TREATMENT FOR ACUTE ISCHEMIC STROKE: HEPARIN,
ANTIPLATELET AGENTS, BOTH OR NEITHER
Multicenter Randomized Clinical Trial of Endovascular Stroke treatment in The Netherlands for Late arrivals: MR CLEAN-LATE
The
benefit of EXtending oral antiCOAgulant treatment after acute Cerebral
Vein Thrombosis (EXCOA-CVT): a cluster observational study
POSTURAL STABILITY IN PATIENT AFTER ISCHEMIC STROKE
DAWN
in full daylight (DWI or CTP Assessment with Clinical Mismatch in the
Triage of Wake Up and Late Presenting Strokes Undergoing
Neurointervention)
PFO Closure in the Gore REDUCE Clinical Trial: Primary Results
No comments:
Post a Comment